(Q34148325)

31 July 2017

title

Dyspnoea and worsening heart failure in patients with acute heart failure: results from the Pre-RELAX-AHF study (English)

1 reference

acute decompensated heart failure

31 July 2017

0 references

1 reference

Gad Cotter

11

0 references

Marco Metra

Marco Metra

1

0 references

Piotr Ponikowski

Piotr Ponikowski

6

0 references

Gerasimos Filippatos

5

Gerasimos Filippatos

1 reference

31 July 2017

3

G Michael Felker

1 reference

31 July 2017

2

John R Teerlink

1 reference

31 July 2017

9

Adriaan A Voors

1 reference

31 July 2017

4

Barry H Greenberg

1 reference

31 July 2017

Beth Davison Weatherley

10

Beth Davison Weatherley

1 reference

31 July 2017

7

Sam L Teichman

1 reference

31 July 2017

8

Elaine Unemori

1 reference

31 July 2017

publication date

22 August 2010

1 reference

European Journal of Heart Failure

31 July 2017

published in

1 reference

31 July 2017

volume

12

1 reference

31 July 2017

issue

10

1 reference

31 July 2017

page(s)

1130-1139

1 reference

Dyspnoea in patients with acute heart failure: an analysis of its clinical course, determinants, and relationship to 60-day outcomes in the PROTECT pilot study

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944016

The impact of early standard therapy on dyspnoea in patients with acute heart failure: the URGENT-dyspnoea study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944016

Effects of tolvaptan on dyspnoea relief from the EVEREST trials

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944016

Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944016

Acute heart failure syndromes

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944016

Vasodilators in the treatment of acute heart failure: what we know, what we don't

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944016

Changing preferences for survival after hospitalization with advanced heart failure

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944016

Improvements in signs and symptoms during hospitalization for acute heart failure follow different patterns and depend on the measurement scales used: an international, prospective registry to evaluate the evolution of measures of disease severity i

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944016

The PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944016

Overview of emerging pharmacologic agents for acute heart failure syndromes

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944016

Fluid overload in acute heart failure--re-distribution and other mechanisms beyond fluid accumulation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944016

Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944016

Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944016

Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944016

Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944016

Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944016

Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944016

Dyspnea as an end point in clinical trials of therapies for acute decompensated heart failure

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944016

The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure-a meta-regression analysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944016

Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944016

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology

5 July 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ132

Demographics, clinical characteristics, and outcomes of patients hospitalized for decompensated heart failure: observations from the IMPACT-HF registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ132

Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ132

Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ132

Early worsening heart failure in patients admitted with acute heart failure--a new outcome measure associated with long-term prognosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ132

Physician-determined worsening heart failure: a novel definition for early worsening heart failure in patients hospitalized for acute heart failure--association with signs and symptoms, hospitalization duration, and 60-day outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ132

Early worsening heart failure in patients admitted for acute heart failure: time course, hemodynamic predictors, and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ132

Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ132

Characteristics, outcomes, and predictors of mortality at 3 months and 1 year in patients hospitalized for acute heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ132

Evaluating dyspnoea in acute heart failure: progress at last!

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ132

Phase III clinical trial end points in acute heart failure syndromes: A virtual roundtable with the acute heart failure syndromes international working group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ132

A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ132

Acute heart failure associated with high admission blood pressure - A distinct vascular disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ132

2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Deve

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20732868

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/EURJHF/HFQ132

1 reference

31 July 2017

1 reference

31 July 2017

1 reference